ICD-10-CM Billable Code

L73.2

Hidradenitis suppurativa

Clinical Classification Guidelines

Medical Intelligence & Overview

Hidradenitis suppurativa, also known as acne inversa, is a chronic skin condition characterized by the development of swollen, painful lumps under the skin. These lumps often occur in areas where the skin rubs together, such as the armpits, groin, buttocks, and under the breasts. Over time, these lumps can become infected, form abscesses, and lead to scarring. The condition can significantly impact an individual's quality of life, causing discomfort, pain, and emotional distress.

Causes & Symptoms

Clinical Causes: Genetic factors that predispose individuals to develop the condition Hormonal influences, especially fluctuations that may trigger flare-ups Obesity, which increases skin friction and sweat production Hormone imbalances, such as those seen in conditions like polycystic ovary syndrome (PCOS) Lifestyle factors including smoking and poor hygiene Problems with immune system regulation leading to abnormal skin responses Friction and pressure in sensitive areas

Key Symptoms: Painful, pea-sized bumps that often cluster together Increased swelling and redness around the lesions Formation of abscesses that can drain pus Thickened, scarred skin over time Foul odor from infected areas Tunnels or sinus tracts developing under the skin connecting lumps Recurrent episodes that may lead to permanent skin damage

Diagnostic & Treatment

Diagnosis Path: Diagnosis of hidradenitis suppurativa is primarily clinical, based on the characteristic appearance of skin lesions and their location. Healthcare providers may perform a physical examination and review the patient's medical history. In some cases, additional tests such as bacterial cultures or biopsies are conducted to rule out other skin conditions or infections. The Hurley staging system is often used to assess the severity of the disease, guiding treatment options.

Treatment Protocols: While there is no cure for hidradenitis suppurativa, various management strategies aim to reduce symptoms, prevent flare-ups, and minimize scarring. These include: - **Lifestyle modifications:** Maintaining a healthy weight, quitting smoking, and practicing good hygiene - **Medications:** Antibiotics for infection control, anti-inflammatory drugs, hormonal therapies, and retinoids - **Biologic therapies:** Tumor necrosis factor (TNF) inhibitors like adalimumab for moderate to severe cases - **Surgical interventions:** Incision and drainage, laser therapy, or excision of affected skin areas in severe cases - **Supportive care:** Pain management, wound care, and psychological support to address emotional impacts of the condition

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L73.2 a billable ICD-10 code?
Yes, L73.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L73.2?
Clinical documentation must specify the nature of Hidradenitis suppurativa and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

hidradenitis suppurativa